ITBO910163A0 - Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica - Google Patents

Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica

Info

Publication number
ITBO910163A0
ITBO910163A0 IT91BO163A ITBO910163A ITBO910163A0 IT BO910163 A0 ITBO910163 A0 IT BO910163A0 IT 91BO163 A IT91BO163 A IT 91BO163A IT BO910163 A ITBO910163 A IT BO910163A IT BO910163 A0 ITBO910163 A0 IT BO910163A0
Authority
IT
Italy
Prior art keywords
diabetic
glycosaminoglicans
treatment
neuropathy
nephropathy
Prior art date
Application number
IT91BO163A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann filed Critical Alfa Wassermann
Priority to ITBO910163A priority Critical patent/IT1245907B/it
Publication of ITBO910163A0 publication Critical patent/ITBO910163A0/it
Priority to DE69212620T priority patent/DE69212620T2/de
Priority to EP92105692A priority patent/EP0513513B1/en
Priority to US07/871,048 priority patent/US5236910A/en
Priority to CA002066785A priority patent/CA2066785C/en
Priority to KR1019920008367A priority patent/KR970005181B1/ko
Publication of ITBO910163A1 publication Critical patent/ITBO910163A1/it
Application granted granted Critical
Publication of IT1245907B publication Critical patent/IT1245907B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ITBO910163A 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. IT1245907B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITBO910163A IT1245907B (it) 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
DE69212620T DE69212620T2 (de) 1991-05-17 1992-04-02 Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
EP92105692A EP0513513B1 (en) 1991-05-17 1992-04-02 Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
US07/871,048 US5236910A (en) 1991-05-17 1992-04-20 Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
CA002066785A CA2066785C (en) 1991-05-17 1992-04-22 Glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
KR1019920008367A KR970005181B1 (ko) 1991-05-17 1992-05-18 글리코스아미노글리칸을 주성분으로 하는 당뇨병 치료제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910163A IT1245907B (it) 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Publications (3)

Publication Number Publication Date
ITBO910163A0 true ITBO910163A0 (it) 1991-05-17
ITBO910163A1 ITBO910163A1 (it) 1992-11-17
IT1245907B IT1245907B (it) 1994-10-25

Family

ID=11337489

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910163A IT1245907B (it) 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Country Status (6)

Country Link
US (1) US5236910A (it)
EP (1) EP0513513B1 (it)
KR (1) KR970005181B1 (it)
CA (1) CA2066785C (it)
DE (1) DE69212620T2 (it)
IT (1) IT1245907B (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
IT1271685B (it) * 1994-08-03 1997-06-04 Crinos Industria Farmaco Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll AG, 67061 Ludwigshafen Organprotektive Lösungen
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
AU782661B2 (en) * 1999-06-30 2005-08-18 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
WO2001002855A1 (en) * 1999-07-01 2001-01-11 Scios Inc. Prevention and treatment of amyloid-associated disorders
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US20040038932A1 (en) * 2000-09-08 2004-02-26 Jack Hirsh Antithrombotic compositions
US20030013680A1 (en) * 2001-06-12 2003-01-16 Keryx Methods using glycosaminoglycans for the treatment of nephropathy
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
KR20050119149A (ko) * 2003-03-28 2005-12-20 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 말초 신경 질환의 치료 및/또는 예방을 위한 클루스테린의용도
AU2005292202A1 (en) * 2004-10-01 2006-04-13 Keryx Biopharmaceuticals, Inc. Methods using glycosaminoglycans for the treatment of kidney disease
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DE102005017799A1 (de) * 2005-04-18 2006-10-19 Abbott Gmbh & Co. Kg Verwendung von Heparin und Heparinderivaten zur Modulation des Neuritenwachstum-kontrollierenden Nogo-Rezeptors
JP5622346B2 (ja) * 2006-05-19 2014-11-12 愛知県 神経細胞の細胞死抑制剤等
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
GB0714500D0 (en) * 2007-07-25 2007-09-05 Hunter Fleming Ltd composition and treatment
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
ES2340902B1 (es) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
EP2550004A4 (en) * 2010-03-12 2014-07-02 Univ Australian SUBSTITUTE THERAPY WITH HEPARAN SULFATE
IT1401253B1 (it) * 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3875349D1 (de) * 1988-06-27 1992-11-19 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.

Also Published As

Publication number Publication date
EP0513513B1 (en) 1996-08-07
DE69212620D1 (de) 1996-09-12
DE69212620T2 (de) 1996-11-28
CA2066785A1 (en) 1992-11-18
EP0513513A1 (en) 1992-11-19
US5236910A (en) 1993-08-17
KR970005181B1 (ko) 1997-04-14
IT1245907B (it) 1994-10-25
CA2066785C (en) 1999-01-12
ITBO910163A1 (it) 1992-11-17
KR920021153A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
ITBO910163A0 (it) Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica
MX9204301A (es) Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico.
DE69022506T2 (de) Saugfähiges Gewebegebilde und Gebrauch desselben.
DE69220195D1 (de) Entwicklungsgerät und damit ausgestattete Prozesseinheit
DE59004453D1 (de) Farbstoffmischung und deren Verwendung.
MX151696A (es) Mejoras en construccion que incluye una unidad de fuente de gas,para uso en camas ajustables y lo similar
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
DE69219962D1 (de) Zylinderaufbau und Gerät hiermit
DE68907723T2 (de) Holzstruktur und rollenpresse dazu.
ITBO930205A0 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
DE59009878D1 (de) Farbstoffmischungen und deren Verwendung.
ITMI932412A1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ITMI912509A1 (it) Uso della nimesulide nel trattamento della cataratta
DE59208182D1 (de) Farbstoffmischungen und deren Verwendung
ITMI911146A1 (it) Agente antiarteriosclerotico, sua preparazione ed uso
DE69029051T2 (de) Cache-Speicher und verwandtes Übereinstimmungsprotokoll
ITMI941064A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.
DE59008017D1 (de) Farbstoffmischungen und deren Verwendung.
DE59007243D1 (de) Farbstoffmischungen und deren Verwendung.
DE9402656U1 (de) Führungsbüchse und längenverstellbare Säule mit Führungsbüchse
ITMI950773A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete mellito
IT1229566B (it) Gel di antracicline e loro uso terapeutico.
ITFI930069A0 (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423